- Home
- TSBK vs VNDA Comparison
TSBK vs VNDA Comparison
Compare TSBK & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- VNDA
- Stock Information
- Founded
- TSBK 1915
- VNDA 2002
- Country
- TSBK United States
- VNDA United States
- Employees
- TSBK N/A
- VNDA N/A
- Industry
- TSBK Banks
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- TSBK Finance
- VNDA Health Care
- Exchange
- TSBK Nasdaq
- VNDA Nasdaq
- Market Cap
- TSBK 274.5M
- VNDA 249.4M
- IPO Year
- TSBK 1998
- VNDA 2006
- Fundamental
- Price
- TSBK $31.46
- VNDA $5.27
- Analyst Decision
- TSBK
- VNDA Strong Buy
- Analyst Count
- TSBK 0
- VNDA 2
- Target Price
- TSBK N/A
- VNDA $16.50
- AVG Volume (30 Days)
- TSBK 15.9K
- VNDA 567.7K
- Earning Date
- TSBK 10-28-2025
- VNDA 11-05-2025
- Dividend Yield
- TSBK 3.31%
- VNDA N/A
- EPS Growth
- TSBK 12.22
- VNDA N/A
- EPS
- TSBK 3.40
- VNDA N/A
- Revenue
- TSBK $78,338,000.00
- VNDA $203,467,000.00
- Revenue This Year
- TSBK N/A
- VNDA $15.45
- Revenue Next Year
- TSBK N/A
- VNDA $37.82
- P/E Ratio
- TSBK $9.25
- VNDA N/A
- Revenue Growth
- TSBK 5.31
- VNDA 11.78
- 52 Week Low
- TSBK $27.51
- VNDA $3.81
- 52 Week High
- TSBK $38.08
- VNDA $5.59
- Technical
- Relative Strength Index (RSI)
- TSBK 36.53
- VNDA 58.91
- Support Level
- TSBK $30.96
- VNDA $5.16
- Resistance Level
- TSBK $32.63
- VNDA $5.54
- Average True Range (ATR)
- TSBK 0.69
- VNDA 0.22
- MACD
- TSBK -0.17
- VNDA -0.01
- Stochastic Oscillator
- TSBK 11.15
- VNDA 61.33
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. It has one reportable operating segment which is defined as community banking in western Washington under the operating name Timberland Bank. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. It also offers loans to real estate, including residential and commercial, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.